Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients

NCT01226537 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT01226537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
Lead sponsor
Hamad Medical Corporation
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2012
Completion date
December 31, 2014
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

because the body does not produce enough insulin,, is produced., it is a group of metabolic diseases in, or because cells do not respond to the insulin that, which a person has high blood sugar, either